Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2019, Vol. 142, No. 2

Editorial Comment

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 59–60. https://doi.org/10.1159/000496380
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 61–63. https://doi.org/10.1159/000496449

Review

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 64–70. https://doi.org/10.1159/000497430

Original Paper

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 71–78. https://doi.org/10.1159/000496820
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 79–86. https://doi.org/10.1159/000495335

Case Report

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 87–91. https://doi.org/10.1159/000495601
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 92–97. https://doi.org/10.1159/000497348
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 98–104. https://doi.org/10.1159/000498842
Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 105–112. https://doi.org/10.1159/000498945

Brief Communication

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 113–119. https://doi.org/10.1159/000499524

Letter to the Editor

Subject Area: Hematology , Oncology
Acta Haematol (2019) 142 (2): 120–122. https://doi.org/10.1159/000494797
Close Modal

or Create an Account

Close Modal
Close Modal